Zymeworks (ZYME) Shares Outstanding (Weighted Average) (2021 - 2026)

Zymeworks has disclosed Shares Outstanding (Weighted Average) across 6 years of filings, most recently posting $74.7 million for Q1 2026.

• Shares Outstanding (Weighted Average) for Q1 2026 came in at $74.7 million, down 0.67% year-over-year; the trailing twelve-month figure through Mar 2026 was $74.7 million (down 0.67% YoY), and the FY2025 annual result was $75.4 million, down 0.58% from the prior year.
• Shares Outstanding (Weighted Average) came in at $74.7 million for Q1 2026 at Zymeworks, down from $75.4 million in the prior quarter.
• In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $76.3 million in Q2 2024 to a low of $61.4 million in Q1 2022.
• The 5-year median for Shares Outstanding (Weighted Average) is $74.7 million (2026), against an average of $71.2 million.
• Across the five-year window, Shares Outstanding (Weighted Average) gained 28.69% in 2022 and fell 1.37% in 2025, its largest moves.
• Zymeworks' Shares Outstanding (Weighted Average) stood at $65.2 million in 2022, then climbed by 5.63% to $68.9 million in 2023, then grew by 10.14% to $75.8 million in 2024, then fell by 0.58% to $75.4 million in 2025, then dropped by 0.98% to $74.7 million in 2026.
• The last three Shares Outstanding (Weighted Average) figures came in at $74.7 million (Q1 2026), $75.4 million (Q4 2025), and $75.4 million (Q3 2025), per Business Quant data.